Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RushNet, Inc. (RSHN) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -74.1%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue -74.1%, EPS 0.0%, free cash flow +66.7% with operating margin -38.3% and ROIC -10.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RSHN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RSHN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RSHN Max Drawdown
-50.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RSHN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$129.9K
-128.4% YoY
Free Cash Flow
-$28.3K
-102.7% YoY
Revenue Growth
-74.1%
EPS Growth
+0.0%
Gross Margin
61.8%
Net Margin
-34.0%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2M | 7M | 6M | 4M | 0 |
| Gross Profit | 1M | 5M | 4M | 3M | 0 |
| Operating Income | -685K | -622K | 593K | 950K | -128K |
| EBITDA | -615K | -302K | 860K | 974K | -128K |
| Net Income | -607K | -665K | 164K | 458K | -130K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 22K | 34K | 275K | 97K | 272 |
| Total Assets | 6M | 7M | 8M | 7M | 60K |
| Total Liabilities | 6M | 7M | 7M | 6M | 248K |
| Shareholder Equity | -191K | 415K | 994K | 504K | -188K |
| Total Debt | 5M | 6M | 6M | 6M | 0 |
| Net Debt | 5M | 6M | 6M | 6M | -272 |
Cash flow positioning
Latest Full Year
Operating Cash Flow
28K
-102.7% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
28K
-102.7% YoY
Key ratios
Gross Margin
61.8%
Operating Margin
-38.3%
Net Margin
-34.0%
ROE
-542.2%
Debt / Equity
-25.20x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.